Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Endometrial Neoplasms Phase 2 ClinicalTrials
Endometrial Neoplasms Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms Phase 1/Phase 2 ClinicalTrials
Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms Phase 3 ClinicalTrials
CONTENTS